Frontiers in Clinical Drug Research - CNS and Neurological Disorders:
Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series co...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Sharjah :
Bentham Science Publishers,
2023.
|
| Schriftenreihe: | Frontiers in Clinical Drug Research - CNS and Neurological Disorders Series.
|
| Schlagworte: | |
| Online-Zugang: | DE-862 DE-863 |
| Zusammenfassung: | Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurologica. |
| Beschreibung: | Description based upon print version of record. Target Specific Nanoparticles |
| Beschreibung: | 1 online resource (339 p.). |
| ISBN: | 9815123319 9789815123319 |
Internformat
MARC
| LEADER | 00000cam a2200000Mu 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-on1382694986 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu|||||||| | ||
| 008 | 231202s2023 xx o ||| 0 eng d | ||
| 040 | |a EBLCP |b eng |c EBLCP |d OCLCO |d OCLCQ |d OCLCL |d N$T |d OCLCO | ||
| 020 | |a 9815123319 | ||
| 020 | |a 9789815123319 |q (electronic bk.) | ||
| 035 | |a (OCoLC)1382694986 | ||
| 050 | 4 | |a R855.3 | |
| 082 | 7 | |a 610.28 |q OCoLC |2 23/eng/20231120 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Amtul, Zareen. | |
| 245 | 1 | 0 | |a Frontiers in Clinical Drug Research - CNS and Neurological Disorders |h [electronic resource]. |
| 260 | |a Sharjah : |b Bentham Science Publishers, |c 2023. | ||
| 300 | |a 1 online resource (339 p.). | ||
| 490 | 1 | |a Frontiers in Clinical Drug Research - CNS and Neurological Disorders Series ; |v v.11 | |
| 500 | |a Description based upon print version of record. | ||
| 505 | 0 | |a Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases | |
| 505 | 8 | |a Flávia Pereira Dias Viegas1,3, Vanessa Silva Gontijo1,2, Matheus de Freitas Silva1,3, Cindy Juliet Cristancho Ortiz1,3, Graziella dos Reis Rosa Franco1,3, Januário Tomás Ernesto1,2, Caio Miranda Damásio1, Gabriel Pinto da Silva Fonseca1, Isabela Marie Fernandes Silva1, Larissa Emika Massuda1, Maria Fernanda da Silva1, Thâmara Gaspar Campos1, Priscila da Mota Braga1 and Claudio Viegas, Jr.1,2,3,* -- INTRODUCTION -- THE MTDLS PARADIGM AND MOLECULAR HYBRIDIZATION (MH) AS A TOOL IN DRUG DESIGN -- GENERAL ASPECTS OF MULTIFACTORIAL PATHOGENESIS IN NDS -- Alzheimer's Disease (AD) | |
| 505 | 8 | |a Parkinson's Disease (PD) -- Amyotrophic Lateral Sclerosis (ALS) -- Huntington's Disease (HD) -- MOLECULAR HYBRIDS AND CHEMICAL DIVERSITY OF MULTIFUNCTIONAL LIGANDS RATIONALLY DESIGNED AS NEW DRUG CANDIDATES FOR NDS -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENTS -- REFERENCES -- Drugs For Relapse Prevention in Addiction:Review of Psychological and Neurological Factors,Genetics and Neurobiological Mechanisms -- Neuroprotective Activities of Cinnamic Acids and their Derivatives -- Pronit Biswas1,*, Rajesh Singh Yadav1 and Juli Jain2 -- INTRODUCTION | |
| 505 | 8 | |a CELL DEATH IN NEURODEGENERATION -- CINNAMIC ACID -- Naturally Occurring Cinnamic Acid Derivatives -- Synthetic Derivatives of Cinnamic Acid -- PHARMACOLOGICAL ACTIVITIES OF CINNAMIC ACIDS AND THEIR DERIVATIVES IN NEURODEGENERATIVE DISEASES -- Parkinson's Disease -- Alzheimer's Disease -- Huntington's Disease -- Prion Disease -- Ischemic Brain Injury -- FUTURE CHALLENGES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES | |
| 505 | 8 | |a Phytosome for Targeted Delivery of Natural Compounds: Improving Efficacy, Bioavailability, and Delivery across BBB for the Treatment of Alzheimer's Disease -- Prashant Tiwari*, 1, Geetha KM1, Shweta Shrivastava2, Yogita Kumari2, Rajni Kant Panik3, Pankaj Kumar Singh4, Dileep Kumar5 and Pratap Kumar Sahu6 -- INTRODUCTION -- Conventional Therapy Against AD -- Blood Brain Barrier and AD -- Neuroprotective Potential of Herbal Drugs -- Herbal Drugs Used in AD -- Nanotherapeutics to Improve BBB Permeability -- Polymeric Nanoparticles -- Nanogels -- Solid Lipid Nanoparticles -- Nano Lipid Carrier | |
| 500 | |a Target Specific Nanoparticles | ||
| 520 | |a Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurologica. | ||
| 650 | 0 | |a Biopharmaceutics. |0 http://id.loc.gov/authorities/subjects/sh85014252 | |
| 650 | 0 | |a Drugs |x Design. |0 http://id.loc.gov/authorities/subjects/sh88001157 | |
| 650 | 0 | |a Medical innovations. |0 http://id.loc.gov/authorities/subjects/sh85082946 | |
| 650 | 0 | |a Pharmaceutical chemistry. |0 http://id.loc.gov/authorities/subjects/sh85023026 | |
| 650 | 2 | |a Biopharmaceutics |0 https://id.nlm.nih.gov/mesh/D001702 | |
| 650 | 2 | |a Drug Design |0 https://id.nlm.nih.gov/mesh/D015195 | |
| 650 | 2 | |a Chemistry, Pharmaceutical |0 https://id.nlm.nih.gov/mesh/D002626 | |
| 650 | 6 | |a Biopharmacie. | |
| 650 | 6 | |a Médicaments |x Conception. | |
| 650 | 6 | |a Médecine |x Innovations. | |
| 650 | 6 | |a Chimie pharmaceutique. | |
| 758 | |i has work: |a CNS and neurological disorders Volume 2 Frontiers in clinical drug research (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFBwc8f6WpYTjF8Kw8qDC3 |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Amtul, Zareen |t Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11 |d Sharjah : Bentham Science Publishers,c2023 |z 9789815123326 |
| 830 | 0 | |a Frontiers in Clinical Drug Research - CNS and Neurological Disorders Series. | |
| 966 | 4 | 0 | |l DE-862 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3609427 |3 Volltext |
| 966 | 4 | 0 | |l DE-863 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3609427 |3 Volltext |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL30593693 | ||
| 938 | |a EBSCOhost |b EBSC |n 3609427 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-862 | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-on1382694986 |
|---|---|
| _version_ | 1826942359163633664 |
| adam_text | |
| any_adam_object | |
| author | Amtul, Zareen |
| author_facet | Amtul, Zareen |
| author_role | |
| author_sort | Amtul, Zareen |
| author_variant | z a za |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | R855 |
| callnumber-raw | R855.3 |
| callnumber-search | R855.3 |
| callnumber-sort | R 3855.3 |
| callnumber-subject | R - General Medicine |
| collection | ZDB-4-EBA |
| contents | Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases Flávia Pereira Dias Viegas1,3, Vanessa Silva Gontijo1,2, Matheus de Freitas Silva1,3, Cindy Juliet Cristancho Ortiz1,3, Graziella dos Reis Rosa Franco1,3, Januário Tomás Ernesto1,2, Caio Miranda Damásio1, Gabriel Pinto da Silva Fonseca1, Isabela Marie Fernandes Silva1, Larissa Emika Massuda1, Maria Fernanda da Silva1, Thâmara Gaspar Campos1, Priscila da Mota Braga1 and Claudio Viegas, Jr.1,2,3,* -- INTRODUCTION -- THE MTDLS PARADIGM AND MOLECULAR HYBRIDIZATION (MH) AS A TOOL IN DRUG DESIGN -- GENERAL ASPECTS OF MULTIFACTORIAL PATHOGENESIS IN NDS -- Alzheimer's Disease (AD) Parkinson's Disease (PD) -- Amyotrophic Lateral Sclerosis (ALS) -- Huntington's Disease (HD) -- MOLECULAR HYBRIDS AND CHEMICAL DIVERSITY OF MULTIFUNCTIONAL LIGANDS RATIONALLY DESIGNED AS NEW DRUG CANDIDATES FOR NDS -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENTS -- REFERENCES -- Drugs For Relapse Prevention in Addiction:Review of Psychological and Neurological Factors,Genetics and Neurobiological Mechanisms -- Neuroprotective Activities of Cinnamic Acids and their Derivatives -- Pronit Biswas1,*, Rajesh Singh Yadav1 and Juli Jain2 -- INTRODUCTION CELL DEATH IN NEURODEGENERATION -- CINNAMIC ACID -- Naturally Occurring Cinnamic Acid Derivatives -- Synthetic Derivatives of Cinnamic Acid -- PHARMACOLOGICAL ACTIVITIES OF CINNAMIC ACIDS AND THEIR DERIVATIVES IN NEURODEGENERATIVE DISEASES -- Parkinson's Disease -- Alzheimer's Disease -- Huntington's Disease -- Prion Disease -- Ischemic Brain Injury -- FUTURE CHALLENGES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES Phytosome for Targeted Delivery of Natural Compounds: Improving Efficacy, Bioavailability, and Delivery across BBB for the Treatment of Alzheimer's Disease -- Prashant Tiwari*, 1, Geetha KM1, Shweta Shrivastava2, Yogita Kumari2, Rajni Kant Panik3, Pankaj Kumar Singh4, Dileep Kumar5 and Pratap Kumar Sahu6 -- INTRODUCTION -- Conventional Therapy Against AD -- Blood Brain Barrier and AD -- Neuroprotective Potential of Herbal Drugs -- Herbal Drugs Used in AD -- Nanotherapeutics to Improve BBB Permeability -- Polymeric Nanoparticles -- Nanogels -- Solid Lipid Nanoparticles -- Nano Lipid Carrier |
| ctrlnum | (OCoLC)1382694986 |
| dewey-full | 610.28 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610.28 |
| dewey-search | 610.28 |
| dewey-sort | 3610.28 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05471cam a2200553Mu 4500</leader><controlfield tag="001">ZDB-4-EBA-on1382694986</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu||||||||</controlfield><controlfield tag="008">231202s2023 xx o ||| 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">EBLCP</subfield><subfield code="b">eng</subfield><subfield code="c">EBLCP</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCL</subfield><subfield code="d">N$T</subfield><subfield code="d">OCLCO</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9815123319</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9789815123319</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1382694986</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R855.3</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">610.28</subfield><subfield code="q">OCoLC</subfield><subfield code="2">23/eng/20231120</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Amtul, Zareen.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Frontiers in Clinical Drug Research - CNS and Neurological Disorders</subfield><subfield code="h">[electronic resource].</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Sharjah :</subfield><subfield code="b">Bentham Science Publishers,</subfield><subfield code="c">2023.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (339 p.).</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Frontiers in Clinical Drug Research - CNS and Neurological Disorders Series ;</subfield><subfield code="v">v.11</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based upon print version of record.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Flávia Pereira Dias Viegas1,3, Vanessa Silva Gontijo1,2, Matheus de Freitas Silva1,3, Cindy Juliet Cristancho Ortiz1,3, Graziella dos Reis Rosa Franco1,3, Januário Tomás Ernesto1,2, Caio Miranda Damásio1, Gabriel Pinto da Silva Fonseca1, Isabela Marie Fernandes Silva1, Larissa Emika Massuda1, Maria Fernanda da Silva1, Thâmara Gaspar Campos1, Priscila da Mota Braga1 and Claudio Viegas, Jr.1,2,3,* -- INTRODUCTION -- THE MTDLS PARADIGM AND MOLECULAR HYBRIDIZATION (MH) AS A TOOL IN DRUG DESIGN -- GENERAL ASPECTS OF MULTIFACTORIAL PATHOGENESIS IN NDS -- Alzheimer's Disease (AD)</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Parkinson's Disease (PD) -- Amyotrophic Lateral Sclerosis (ALS) -- Huntington's Disease (HD) -- MOLECULAR HYBRIDS AND CHEMICAL DIVERSITY OF MULTIFUNCTIONAL LIGANDS RATIONALLY DESIGNED AS NEW DRUG CANDIDATES FOR NDS -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENTS -- REFERENCES -- Drugs For Relapse Prevention in Addiction:Review of Psychological and Neurological Factors,Genetics and Neurobiological Mechanisms -- Neuroprotective Activities of Cinnamic Acids and their Derivatives -- Pronit Biswas1,*, Rajesh Singh Yadav1 and Juli Jain2 -- INTRODUCTION</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">CELL DEATH IN NEURODEGENERATION -- CINNAMIC ACID -- Naturally Occurring Cinnamic Acid Derivatives -- Synthetic Derivatives of Cinnamic Acid -- PHARMACOLOGICAL ACTIVITIES OF CINNAMIC ACIDS AND THEIR DERIVATIVES IN NEURODEGENERATIVE DISEASES -- Parkinson's Disease -- Alzheimer's Disease -- Huntington's Disease -- Prion Disease -- Ischemic Brain Injury -- FUTURE CHALLENGES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES</subfield></datafield><datafield tag="505" ind1="8" ind2=" "><subfield code="a">Phytosome for Targeted Delivery of Natural Compounds: Improving Efficacy, Bioavailability, and Delivery across BBB for the Treatment of Alzheimer's Disease -- Prashant Tiwari*, 1, Geetha KM1, Shweta Shrivastava2, Yogita Kumari2, Rajni Kant Panik3, Pankaj Kumar Singh4, Dileep Kumar5 and Pratap Kumar Sahu6 -- INTRODUCTION -- Conventional Therapy Against AD -- Blood Brain Barrier and AD -- Neuroprotective Potential of Herbal Drugs -- Herbal Drugs Used in AD -- Nanotherapeutics to Improve BBB Permeability -- Polymeric Nanoparticles -- Nanogels -- Solid Lipid Nanoparticles -- Nano Lipid Carrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Target Specific Nanoparticles</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurologica.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Biopharmaceutics.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85014252</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Drugs</subfield><subfield code="x">Design.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh88001157</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Medical innovations.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85082946</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Pharmaceutical chemistry.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85023026</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Biopharmaceutics</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D001702</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Drug Design</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D015195</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Chemistry, Pharmaceutical</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D002626</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Biopharmacie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médicaments</subfield><subfield code="x">Conception.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Médecine</subfield><subfield code="x">Innovations.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Chimie pharmaceutique.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">CNS and neurological disorders Volume 2 Frontiers in clinical drug research (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFBwc8f6WpYTjF8Kw8qDC3</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Amtul, Zareen</subfield><subfield code="t">Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11</subfield><subfield code="d">Sharjah : Bentham Science Publishers,c2023</subfield><subfield code="z">9789815123326</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Frontiers in Clinical Drug Research - CNS and Neurological Disorders Series.</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-862</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3609427</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="4" ind2="0"><subfield code="l">DE-863</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=3609427</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL30593693</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">3609427</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-862</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-on1382694986 |
| illustrated | Not Illustrated |
| indexdate | 2025-03-18T14:26:45Z |
| institution | BVB |
| isbn | 9815123319 9789815123319 |
| language | English |
| oclc_num | 1382694986 |
| open_access_boolean | |
| owner | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-862 DE-BY-FWS DE-863 DE-BY-FWS |
| physical | 1 online resource (339 p.). |
| psigel | ZDB-4-EBA FWS_PDA_EBA ZDB-4-EBA |
| publishDate | 2023 |
| publishDateSearch | 2023 |
| publishDateSort | 2023 |
| publisher | Bentham Science Publishers, |
| record_format | marc |
| series | Frontiers in Clinical Drug Research - CNS and Neurological Disorders Series. |
| series2 | Frontiers in Clinical Drug Research - CNS and Neurological Disorders Series ; |
| spelling | Amtul, Zareen. Frontiers in Clinical Drug Research - CNS and Neurological Disorders [electronic resource]. Sharjah : Bentham Science Publishers, 2023. 1 online resource (339 p.). Frontiers in Clinical Drug Research - CNS and Neurological Disorders Series ; v.11 Description based upon print version of record. Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases Flávia Pereira Dias Viegas1,3, Vanessa Silva Gontijo1,2, Matheus de Freitas Silva1,3, Cindy Juliet Cristancho Ortiz1,3, Graziella dos Reis Rosa Franco1,3, Januário Tomás Ernesto1,2, Caio Miranda Damásio1, Gabriel Pinto da Silva Fonseca1, Isabela Marie Fernandes Silva1, Larissa Emika Massuda1, Maria Fernanda da Silva1, Thâmara Gaspar Campos1, Priscila da Mota Braga1 and Claudio Viegas, Jr.1,2,3,* -- INTRODUCTION -- THE MTDLS PARADIGM AND MOLECULAR HYBRIDIZATION (MH) AS A TOOL IN DRUG DESIGN -- GENERAL ASPECTS OF MULTIFACTORIAL PATHOGENESIS IN NDS -- Alzheimer's Disease (AD) Parkinson's Disease (PD) -- Amyotrophic Lateral Sclerosis (ALS) -- Huntington's Disease (HD) -- MOLECULAR HYBRIDS AND CHEMICAL DIVERSITY OF MULTIFUNCTIONAL LIGANDS RATIONALLY DESIGNED AS NEW DRUG CANDIDATES FOR NDS -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENTS -- REFERENCES -- Drugs For Relapse Prevention in Addiction:Review of Psychological and Neurological Factors,Genetics and Neurobiological Mechanisms -- Neuroprotective Activities of Cinnamic Acids and their Derivatives -- Pronit Biswas1,*, Rajesh Singh Yadav1 and Juli Jain2 -- INTRODUCTION CELL DEATH IN NEURODEGENERATION -- CINNAMIC ACID -- Naturally Occurring Cinnamic Acid Derivatives -- Synthetic Derivatives of Cinnamic Acid -- PHARMACOLOGICAL ACTIVITIES OF CINNAMIC ACIDS AND THEIR DERIVATIVES IN NEURODEGENERATIVE DISEASES -- Parkinson's Disease -- Alzheimer's Disease -- Huntington's Disease -- Prion Disease -- Ischemic Brain Injury -- FUTURE CHALLENGES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES Phytosome for Targeted Delivery of Natural Compounds: Improving Efficacy, Bioavailability, and Delivery across BBB for the Treatment of Alzheimer's Disease -- Prashant Tiwari*, 1, Geetha KM1, Shweta Shrivastava2, Yogita Kumari2, Rajni Kant Panik3, Pankaj Kumar Singh4, Dileep Kumar5 and Pratap Kumar Sahu6 -- INTRODUCTION -- Conventional Therapy Against AD -- Blood Brain Barrier and AD -- Neuroprotective Potential of Herbal Drugs -- Herbal Drugs Used in AD -- Nanotherapeutics to Improve BBB Permeability -- Polymeric Nanoparticles -- Nanogels -- Solid Lipid Nanoparticles -- Nano Lipid Carrier Target Specific Nanoparticles Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the book series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurologica. Biopharmaceutics. http://id.loc.gov/authorities/subjects/sh85014252 Drugs Design. http://id.loc.gov/authorities/subjects/sh88001157 Medical innovations. http://id.loc.gov/authorities/subjects/sh85082946 Pharmaceutical chemistry. http://id.loc.gov/authorities/subjects/sh85023026 Biopharmaceutics https://id.nlm.nih.gov/mesh/D001702 Drug Design https://id.nlm.nih.gov/mesh/D015195 Chemistry, Pharmaceutical https://id.nlm.nih.gov/mesh/D002626 Biopharmacie. Médicaments Conception. Médecine Innovations. Chimie pharmaceutique. has work: CNS and neurological disorders Volume 2 Frontiers in clinical drug research (Text) https://id.oclc.org/worldcat/entity/E39PCFBwc8f6WpYTjF8Kw8qDC3 https://id.oclc.org/worldcat/ontology/hasWork Print version: Amtul, Zareen Frontiers in Clinical Drug Research - CNS and Neurological Disorders: Volume 11 Sharjah : Bentham Science Publishers,c2023 9789815123326 Frontiers in Clinical Drug Research - CNS and Neurological Disorders Series. |
| spellingShingle | Amtul, Zareen Frontiers in Clinical Drug Research - CNS and Neurological Disorders Frontiers in Clinical Drug Research - CNS and Neurological Disorders Series. Cover -- Title -- Copyright -- End User License Agreement -- Contents -- Preface -- List of Contributors -- Multi-functional Ligands and Molecular Hybridization: Conceptual Aspects and Application in the Innovative Design of Drug Candidate Prototypes for Neurodegenerative Diseases Flávia Pereira Dias Viegas1,3, Vanessa Silva Gontijo1,2, Matheus de Freitas Silva1,3, Cindy Juliet Cristancho Ortiz1,3, Graziella dos Reis Rosa Franco1,3, Januário Tomás Ernesto1,2, Caio Miranda Damásio1, Gabriel Pinto da Silva Fonseca1, Isabela Marie Fernandes Silva1, Larissa Emika Massuda1, Maria Fernanda da Silva1, Thâmara Gaspar Campos1, Priscila da Mota Braga1 and Claudio Viegas, Jr.1,2,3,* -- INTRODUCTION -- THE MTDLS PARADIGM AND MOLECULAR HYBRIDIZATION (MH) AS A TOOL IN DRUG DESIGN -- GENERAL ASPECTS OF MULTIFACTORIAL PATHOGENESIS IN NDS -- Alzheimer's Disease (AD) Parkinson's Disease (PD) -- Amyotrophic Lateral Sclerosis (ALS) -- Huntington's Disease (HD) -- MOLECULAR HYBRIDS AND CHEMICAL DIVERSITY OF MULTIFUNCTIONAL LIGANDS RATIONALLY DESIGNED AS NEW DRUG CANDIDATES FOR NDS -- CONCLUDING REMARKS -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGMENTS -- REFERENCES -- Drugs For Relapse Prevention in Addiction:Review of Psychological and Neurological Factors,Genetics and Neurobiological Mechanisms -- Neuroprotective Activities of Cinnamic Acids and their Derivatives -- Pronit Biswas1,*, Rajesh Singh Yadav1 and Juli Jain2 -- INTRODUCTION CELL DEATH IN NEURODEGENERATION -- CINNAMIC ACID -- Naturally Occurring Cinnamic Acid Derivatives -- Synthetic Derivatives of Cinnamic Acid -- PHARMACOLOGICAL ACTIVITIES OF CINNAMIC ACIDS AND THEIR DERIVATIVES IN NEURODEGENERATIVE DISEASES -- Parkinson's Disease -- Alzheimer's Disease -- Huntington's Disease -- Prion Disease -- Ischemic Brain Injury -- FUTURE CHALLENGES -- CONCLUSION -- CONSENT FOR PUBLICATION -- CONFLICT OF INTEREST -- ACKNOWLEDGEMENTS -- REFERENCES Phytosome for Targeted Delivery of Natural Compounds: Improving Efficacy, Bioavailability, and Delivery across BBB for the Treatment of Alzheimer's Disease -- Prashant Tiwari*, 1, Geetha KM1, Shweta Shrivastava2, Yogita Kumari2, Rajni Kant Panik3, Pankaj Kumar Singh4, Dileep Kumar5 and Pratap Kumar Sahu6 -- INTRODUCTION -- Conventional Therapy Against AD -- Blood Brain Barrier and AD -- Neuroprotective Potential of Herbal Drugs -- Herbal Drugs Used in AD -- Nanotherapeutics to Improve BBB Permeability -- Polymeric Nanoparticles -- Nanogels -- Solid Lipid Nanoparticles -- Nano Lipid Carrier Biopharmaceutics. http://id.loc.gov/authorities/subjects/sh85014252 Drugs Design. http://id.loc.gov/authorities/subjects/sh88001157 Medical innovations. http://id.loc.gov/authorities/subjects/sh85082946 Pharmaceutical chemistry. http://id.loc.gov/authorities/subjects/sh85023026 Biopharmaceutics https://id.nlm.nih.gov/mesh/D001702 Drug Design https://id.nlm.nih.gov/mesh/D015195 Chemistry, Pharmaceutical https://id.nlm.nih.gov/mesh/D002626 Biopharmacie. Médicaments Conception. Médecine Innovations. Chimie pharmaceutique. |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85014252 http://id.loc.gov/authorities/subjects/sh88001157 http://id.loc.gov/authorities/subjects/sh85082946 http://id.loc.gov/authorities/subjects/sh85023026 https://id.nlm.nih.gov/mesh/D001702 https://id.nlm.nih.gov/mesh/D015195 https://id.nlm.nih.gov/mesh/D002626 |
| title | Frontiers in Clinical Drug Research - CNS and Neurological Disorders |
| title_auth | Frontiers in Clinical Drug Research - CNS and Neurological Disorders |
| title_exact_search | Frontiers in Clinical Drug Research - CNS and Neurological Disorders |
| title_full | Frontiers in Clinical Drug Research - CNS and Neurological Disorders [electronic resource]. |
| title_fullStr | Frontiers in Clinical Drug Research - CNS and Neurological Disorders [electronic resource]. |
| title_full_unstemmed | Frontiers in Clinical Drug Research - CNS and Neurological Disorders [electronic resource]. |
| title_short | Frontiers in Clinical Drug Research - CNS and Neurological Disorders |
| title_sort | frontiers in clinical drug research cns and neurological disorders |
| topic | Biopharmaceutics. http://id.loc.gov/authorities/subjects/sh85014252 Drugs Design. http://id.loc.gov/authorities/subjects/sh88001157 Medical innovations. http://id.loc.gov/authorities/subjects/sh85082946 Pharmaceutical chemistry. http://id.loc.gov/authorities/subjects/sh85023026 Biopharmaceutics https://id.nlm.nih.gov/mesh/D001702 Drug Design https://id.nlm.nih.gov/mesh/D015195 Chemistry, Pharmaceutical https://id.nlm.nih.gov/mesh/D002626 Biopharmacie. Médicaments Conception. Médecine Innovations. Chimie pharmaceutique. |
| topic_facet | Biopharmaceutics. Drugs Design. Medical innovations. Pharmaceutical chemistry. Biopharmaceutics Drug Design Chemistry, Pharmaceutical Biopharmacie. Médicaments Conception. Médecine Innovations. Chimie pharmaceutique. |
| work_keys_str_mv | AT amtulzareen frontiersinclinicaldrugresearchcnsandneurologicaldisorders |